Drug company (FDA labeler)
Aarkish Pharmaceuticals NJ Inc.
NDC labeler code: 81005
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Metolazone3 products
- Acetazolamide2 products
- Butalbital and acetaminophenTencon, Allzital · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| May 9, 2023 | ANDA217197 | Acetazolamide ACETAZOLAMIDE | Ne Rx Pharma |
| October 25, 2022 | ANDA216216 | Metolazone METOLAZONE | Ne Rx Pharma |
| August 16, 2022 | ANDA214955 | Butalbital and acetaminophen BUTALBITAL AND ACETAMINOPHEN | Ne Rx Pharma |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026